These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12839621)

  • 1. [PHI+], a novel Sup35-prion variant propagated with non-Gln/Asn oligopeptide repeats in the absence of the chaperone protein Hsp104.
    Crist CG; Nakayashiki T; Kurahashi H; Nakamura Y
    Genes Cells; 2003 Jul; 8(7):603-18. PubMed ID: 12839621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain.
    Toombs JA; Liss NM; Cobble KR; Ben-Musa Z; Ross ED
    PLoS One; 2011; 6(7):e21953. PubMed ID: 21760933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants.
    Shkundina IS; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    Genetics; 2006 Feb; 172(2):827-35. PubMed ID: 16272413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion domain interaction responsible for species discrimination in yeast [PSI+] transmission.
    Hara H; Nakayashiki T; Crist CG; Nakamura Y
    Genes Cells; 2003 Dec; 8(12):925-39. PubMed ID: 14750948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small heat shock protein Hsp31 cooperates with Hsp104 to modulate Sup35 prion aggregation.
    Aslam K; Tsai CJ; Hazbun TR
    Prion; 2016 Nov; 10(6):444-465. PubMed ID: 27690738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion variant maintained only at high levels of the Hsp104 disaggregase.
    Borchsenius AS; Müller S; Newnam GP; Inge-Vechtomov SG; Chernoff YO
    Curr Genet; 2006 Jan; 49(1):21-9. PubMed ID: 16307272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous gln/asn-rich proteins impede the propagation of yeast prions by altering chaperone availability.
    Yang Z; Hong JY; Derkatch IL; Liebman SW
    PLoS Genet; 2013; 9(1):e1003236. PubMed ID: 23358669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of low-oligomeric-weight species for prion propagation in the yeast prion system Sup35/Hsp104.
    Narayanan S; Bösl B; Walter S; Reif B
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9286-91. PubMed ID: 12876196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast Sup35 Prion Structure: Two Types, Four Parts, Many Variants.
    Dergalev AA; Alexandrov AI; Ivannikov RI; Ter-Avanesyan MD; Kushnirov VV
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 104 (Hsp104)-mediated curing of [
    Zhao X; Rodriguez R; Silberman RE; Ahearn JM; Saidha S; Cummins KC; Eisenberg E; Greene LE
    J Biol Chem; 2017 May; 292(21):8630-8641. PubMed ID: 28373280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal domain of yeast Hsp104 chaperone is dispensable for thermotolerance and prion propagation but necessary for curing prions by Hsp104 overexpression.
    Hung GC; Masison DC
    Genetics; 2006 Jun; 173(2):611-20. PubMed ID: 16582428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104.
    Kryndushkin DS; Alexandrov IM; Ter-Avanesyan MD; Kushnirov VV
    J Biol Chem; 2003 Dec; 278(49):49636-43. PubMed ID: 14507919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation preserved in a weak-to-strong or strong-to-weak [PSI+] conversion during transmission to Sup35 prion variants.
    Crist CG; Kurahashi H; Nakayashiki T; Nakamura Y
    Biochimie; 2006 May; 88(5):485-96. PubMed ID: 16364534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new perspective on Hsp104-mediated propagation and curing of the yeast prion [PSI (+) ].
    Helsen CW; Glover JR
    Prion; 2012 Jul; 6(3):234-9. PubMed ID: 22561166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of Hsp104 with yeast prion Sup35 as analyzed by fluorescence cross-correlation spectroscopy.
    Ohta S; Kawai-Noma S; Kitamura A; Pack CG; Kinjo M; Taguchi H
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):28-32. PubMed ID: 24216111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous aggregates promote de novo prion appearance via more than one mechanism.
    Arslan F; Hong JY; Kanneganti V; Park SK; Liebman SW
    PLoS Genet; 2015 Jan; 11(1):e1004814. PubMed ID: 25568955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The life of [PSI].
    Cox B; Tuite M
    Curr Genet; 2018 Feb; 64(1):1-8. PubMed ID: 28653109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae.
    Bailleul PA; Newnam GP; Steenbergen JN; Chernoff YO
    Genetics; 1999 Sep; 153(1):81-94. PubMed ID: 10471702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curing of yeast [PSI+] prion by guanidine inactivation of Hsp104 does not require cell division.
    Wu YX; Greene LE; Masison DC; Eisenberg E
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12789-94. PubMed ID: 16123122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.